| 摘要 |
The invention relates to the use of 5HT1A receptor agonists of formula (I), wherein Het represents (a) or (b), B is a C1-4alkylene group, D is a bond or an ethenylene bridging group, X, Y, Z, A, R, R1 have the meanings given in the description, to treat unvoluntary movements in epilepsy, parkinsonism, Huntington's chorea, tardive dyskinesia, Freidreich's ataxia, presenile dementia and Gilles de la Tourette's syndrome. |
